Working…
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02172950
Recruitment Status : Active, not recruiting
First Posted : June 24, 2014
Last Update Posted : February 6, 2020
Sponsor:
Information provided by (Responsible Party):
CSL Behring

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : July 1, 2025
Estimated Study Completion Date : July 1, 2025